|
Market Closed -
Euronext Paris
16:55:00 10/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 156.40 EUR | -1.32% |
|
-7.24% | +31.43% |
| 09-08 | Rubis posts gold-standard results, telecom operators talk, Novartis has to pull the parachute. |  |
| 08-21 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- IPN Stock
- Consensus Ipsen
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
